---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-172218"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:44:55.060750+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Aligos stockholders approve increase in authorized shares from 300M to 500M and amendment to 2020 incentive plan

## Summary
- Stockholders approved increase in authorized shares from 300M to 500M, effective June 27, 2024.
- Approved amendment to 2020 incentive plan to treat pre-funded warrants with exercise price ≤ $0.01 as common stock for annual share increases.
- Board authorized to effect reverse stock split if deemed in best interests; no immediate action.

## SEC filing metadata
- accession: 0001193125-24-172218
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312524172218/0001193125-24-172218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524172218/d129014d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-172218
- JSON: https://secwatch.observer/filing/0001193125-24-172218.json
- Plain text: https://secwatch.observer/filing/0001193125-24-172218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.